This Week in Nature

In this week's Nature, a group of German scientists reports new insights into the genetic basis of high-risk neuroblastoma, a pediatric cancer that develops from nerve cells. By performing whole-genome sequencing of 39 high-risk and 17 low-risk neuroblastoma tumors, the group found that about 25 percent of high-risk tumors were associated with genetic rearrangements in a region of DNA located near the telomerase reverse transcriptase (TERT) gene.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.